A double-blind, randomized, controlled study of oral pirfenidone for treatment of secondary progressive multiple sclerosis.

A double-blind, randomized, controlled study of oral pirfenidone for treatment of secondary progressive multiple sclerosis.

Item
http://www.wikidata.org/entity/Q42651835
Alzheimer's Disease: Exploring the Role of Inflammation and Implications for TreatmentImproved mitochondrial function underlies the protective effect of pirfenidone against tubulointerstitial fibrosis in 5/6 nephrectomized ratsDrug repurposing: a systematic approach to evaluate candidate oral neuroprotective interventions for secondary progressive multiple sclerosisDefective CFTR leads to aberrant β-catenin activation and kidney fibrosis.The multifaceted role of pirfenidone and its novel targets.Pirfenidone: an anti-fibrotic therapy for progressive kidney disease.Therapeutic targets for treating fibrotic kidney diseasesSustained TNF production by central nervous system infiltrating macrophages promotes progressive autoimmune encephalomyelitis.Treatment trials in progressive MS--current challenges and future directions.Emerging Agents for the Management of Nephrotic Syndrome: Progress to Date.Inhibitory effects of pirfenidone on dendritic cells and lung allograft rejection.Pirfenidone inhibits macrophage infiltration in 5/6 nephrectomized rats.Single- and multiple-dose pharmacokinetics of pirfenidone, an antifibrotic agent, in healthy Chinese volunteers.Diffusion-weighted imaging predicts cognitive impairment in multiple sclerosis.Blockade of sustained tumor necrosis factor in a transgenic model of progressive autoimmune encephalomyelitis limits oligodendrocyte apoptosis and promotes oligodendrocyte maturation.
P2860

A double-blind, randomized, controlled study of oral pirfenidone for treatment of secondary progressive multiple sclerosis.

Item
http://www.wikidata.org/entity/Q42651835
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
A double-blind, randomized, co ...... rogressive multiple sclerosis.
@en
A double-blind, randomized, co ...... rogressive multiple sclerosis.
@nl
type
label
A double-blind, randomized, co ...... rogressive multiple sclerosis.
@en
A double-blind, randomized, co ...... rogressive multiple sclerosis.
@nl
prefLabel
A double-blind, randomized, co ...... rogressive multiple sclerosis.
@en
A double-blind, randomized, co ...... rogressive multiple sclerosis.
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P433
P478
P577
P5875
P698
P921
P356
P1433
P1476
A double-blind, randomized, co ...... rogressive multiple sclerosis.
@en
P2093
P2860
P304
P31
P356
10.1191/1352458505MS1134OA
P433
P478
P577
P5875
P698
P921